Similarly, NRGS mice (NOD/RAG IL2Rγ-/-(NRG) mice harboring the same SCF/GM-CSF/IL-3 transgene) also exhibited improved engraftment of patient AML samples when compared to NRG [5]. This evidence concerns the gene IL3 and acute myeloid leukemia.